<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 17.04.2009 05:15:46[mciao0826] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<treatment  confidence="0.9511911446218017" wordnetid="100658082">
<header>
<title>Treatment for depression</title>
<id>19064282</id>
<revision>
<id>243658300</id>
<timestamp>2008-10-07T14:23:02Z</timestamp>
<contributor>
<username>Cosmic Latte</username>
<id>3190204</id>
</contributor>
</revision>
<categories>
<category>Articles that may contain original research since August 2008</category>
<category>Mental health</category>
<category>Psychiatric treatments</category>
<category>Articles actively undergoing construction</category>
<category>Accuracy disputes from July 2008</category>
</categories>
</header>
<bdy>

<table class="metadata plainlinks ambox ">
<row>
<col>

ambox-notice" style=""</col>
</row>
<row>
<col class="mbox-image"><p>

<image width="50px" src="Crystal_Clear_action_configure.png">
</image>
</p>
</col>
<col style="" class="mbox-text">
 <b>This page is in the middle of an expansion or major revamping.</b>
You are welcome to assist in its construction by editing it as well.<p>

If this article <weblink xlink:type="simple" xlink:href="http://localhost:18088/wiki/index.php?title=Treatment_for_depression&amp;action=history">
has not been edited in several days</weblink>, please remove this template. Consider not tagging with a unless the page hasn't been edited in several days.</p>
</col>
</row>
</table>

<p>

<table class="metadata plainlinks ambox ">
<row>
<col>

ambox-content" style=""</col>
</row>
<row>
<col class="mbox-image"><p>

<image width="40x40px" src="Ambox_content.png">
</image>
</p>
</col>
<col style="" class="mbox-text">
 <p>

This article or section has multiple issues. Please help <b><weblink xlink:type="simple" xlink:href="http://localhost:18088/wiki/index.php?title=Treatment_for_depression&amp;action=edit">
improve the article</weblink></b> or discuss these issues on the .
<list>
<entry level="1" type="bullet">

 It may contain an <b> of published material</b> that conveys ideas not  with the given sources. Tagged since July 2008.</entry>
<entry level="1" type="bullet">

 It may contain improper references to . Tagged since July 2008.</entry>
</list>
</p>
</col>
</row>
</table>
</p>

<p>

<b>Depression</b>, for the purposes of this article, refers to the <link xlink:type="simple" xlink:href="../356/19356.xml">
mental disorder</link> known as <link xlink:type="simple" xlink:href="../389/8389.xml">
major depressive disorder</link>. This kind of depression is a recognised clinical condition and is becoming a common condition in developed countries, where up to 20% of the population is affected by this disorder at some stage of their lives.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref> Patients are usually assessed and managed as <link xlink:type="simple" xlink:href="../869/18973869.xml#xpointer(//*[./st=%22Outpatient_treatment%22])">
outpatients</link>, and only admitted to an  <link xlink:type="simple" xlink:href="../869/18973869.xml#xpointer(//*[./st=%22Inpatient_treatment%22])">
inpatient</link> mental health unit if they are considered to pose a risk to themselves or others. </p>
<p>

The three most commonly indicated treatments for depression are <link xlink:type="simple" xlink:href="../931/24931.xml">
psychotherapy</link>, <link xlink:type="simple" xlink:href="../121/180121.xml">
medication</link>, and <link xlink:type="simple" xlink:href="../093/44093.xml">
electroconvulsive therapy</link>. Psychotherapy is the treatment of choice in those under the age of 18, with medication offered only in conjunction with the former and generally not as a first line agent. Furthermore, pathology in the parents may need to be looked for and addressed in parallel.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>  </p>

<sec>
<st>
 Psychotherapy </st>

<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../931/24931.xml">
Psychotherapy</link></it>
</indent>
<image location="right" width="150px" src="Albert_Ellis_2003_emocionalmente_sentado.jpg" type="thumb">
</image>

There are a number of different psychotherapies for depression, which may be provided to individuals or groups. Psychotherapy can be delivered by a variety of mental health professionals, including psychotherapists, psychiatrists, psychologists, <link xlink:type="simple" xlink:href="../717/146717.xml">
clinical social work</link>ers, counselors, and psychiatric nurses. With more complex and chronic forms of depression the most effective treatment is often considered to be a combination of medication and psychotherapy.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref> Psychotherapy is the treatment of choice in people under 18; medication is offered only in conjunction with the former and generally not as a first line agent. <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>  </p>
<p>

The most studied form of psychotherapy for depression is <it><link xlink:type="simple" xlink:href="../750/5750.xml">
cognitive behavioral therapy</link></it> (CBT), thought to work by teaching clients to learn a set of cognitive and behavioral skills, which they can employ on their own. Earlier research suggested that cognitive-behavioral therapy was not as effective as antidepressant medication in the treatment of depression; however, more recent research suggests that it can perform as well as antidepressants in treating patients with moderate to severe depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref></p>
<p>

For the treatment of adolescent depression, CBT performed no better than <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link>, and significantly worse than the antidepressant <link xlink:type="simple" xlink:href="../680/10153680.xml">
fluoxetine</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref> Combining fluoxetine with CBT appeared to bring no additional benefit<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref> or, at the most, only marginal benefit.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref></p>
<p>

Two randomized, controlled trials of <link xlink:type="simple" xlink:href="../748/5731748.xml">
mindfulness-based cognitive therapy</link> (MBCT), which includes elements of <link xlink:type="simple" xlink:href="../062/20062.xml">
meditation</link>, have been reviewed. MBCT was significantly more effective than "usual care" for the prevention of recurrent depression in patients who had had three or more depressive episodes. According to the review, the "usual care" did not include antidepressant treatment or any psychotherapy, and the improvement observed may have reflected the non-specific or placebo effects.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref></p>
<p>

<it><link xlink:type="simple" xlink:href="../402/10220402.xml">
Interpersonal psychotherapy</link></it> focuses on the social and interpersonal triggers that may cause depression. There is evidence that it is an effective treatment for depression. Here, the therapy takes a structured course with a set number of weekly sessions (often 12) as in the case of CBT, however the focus is on relationships with others. Therapy can be used to help a person develop or improve <link xlink:type="simple" xlink:href="../032/2197032.xml">
interpersonal skills</link> in order to allow him or her to communicate more effectively and reduce stress.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref></p>
<p>

<it><link xlink:type="simple" xlink:href="../585/23585.xml">
Psychoanalysis</link></it>, a school of thought founded by <person wordnetid="100007846" confidence="0.9508927676800064">
<scientist wordnetid="110560637" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../743/26743.xml">
Sigmund Freud</link></scientist>
</person>
 that emphasizes the resolution of unconscious mental conflicts,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref> is used by its practitioners to treat clients presenting with major depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref> A more widely practiced, eclectic technique, called <it><link xlink:type="simple" xlink:href="../718/1549718.xml">
psychodynamic psychotherapy</link></it>, is loosely based on psychoanalysis and has an additional social and interpersonal focus.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref> In a meta-analysis of three controlled trials, psychodynamic psychotherapy was found to be as effective as medication for mild to moderate depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref></p>

</sec>
<sec>
<st>
 Medication </st>

<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
Antidepressant</link></it>
</indent>

To find the most effective pharmaceutical treatment, the dosages of medications must often be adjusted, different combinations of antidepressants tried, or antidepressant changed. Response rates to the first agent administered may be as low as 50%.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref> It may take anywhere from three to eight weeks after the start of medication before its therapeutic effects can be fully discovered. Patients are generally advised not to stop taking an antidepressant suddenly and to continue its use for at least four months to prevent the chance of recurrence. People with chronic depression need to take the medication for the rest of their lives.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref></p>
<p>

<image location="left" width="150px" src="Isoniazid_skeletal.svg" type="thumb">
</image>

<link xlink:type="simple" xlink:href="../581/29581.xml">
Selective serotonin reuptake inhibitors</link> (SSRIs), such as <link xlink:type="simple" xlink:href="../612/149612.xml">
sertraline</link> (Zoloft), <link xlink:type="simple" xlink:href="../304/201304.xml">
escitalopram</link> (Lexapro), <link xlink:type="simple" xlink:href="../680/10153680.xml">
fluoxetine</link> (Prozac), <link xlink:type="simple" xlink:href="../118/124118.xml">
paroxetine</link>, and <link xlink:type="simple" xlink:href="../310/201310.xml">
citalopram</link> are the primary medications considered, due to their relatively mild side effects and broad effect on the symptoms of depression and anxiety. Those who do not respond to the first SSRI tried can be switched to another; such a switch results in improvement in almost 50% of cases.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref>  Another popular option is to switch to the atypical antidepressant <link xlink:type="simple" xlink:href="../579/378579.xml">
bupropion</link> (Wellbutrin) or to add bupropion to the existing therapy;<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref> this strategy is possibly more effective.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref> It is not uncommon for SSRIs to cause or worsen insomnia; the sedating antidepressant <link xlink:type="simple" xlink:href="../555/527555.xml">
mirtazapine</link> (Zispin, Remeron) can be used in such cases.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref> <physical_entity wordnetid="100001930" confidence="0.8">
<substance wordnetid="100020090" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<medicine wordnetid="103740161" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<antidepressant wordnetid="102718811" confidence="0.8">
<agent wordnetid="114778436" confidence="0.8">
<drug wordnetid="103247620" confidence="0.8">
<link xlink:type="simple" xlink:href="../574/520574.xml">
Venlafaxine</link></drug>
</agent>
</antidepressant>
</inhibitor>
</medicine>
</causal_agent>
</substance>
</physical_entity>
 (Effexor) may be moderately more effective than SSRIs;<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref> however, it is not recommended as a first-line treatment because of the higher rate of side effects,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref> and its use is specifically discouraged in children and adolescents.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref>  Fluoxetine is the only antidepressant recommended for people under the age of 18.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref></p>
<p>

<link xlink:type="simple" xlink:href="../494/31494.xml">
Tricyclic antidepressant</link>s have more side effects than SSRIs and are usually reserved for the treatment of inpatients, for whom the tricyclic antidepressant <link xlink:type="simple" xlink:href="../678/583678.xml">
amitriptyline</link>, in particular, appears to be more effective.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref>
A different class of antidepressants, the monoamine oxidase inhibitors, have historically been plagued by questionable efficacy and life-threatening adverse effects. They are still used only rarely, although newer agents of this class, with a better side effect profile, have been developed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref></p>

<ss1>
<st>
 Augmentation </st>
<p>

Physicians often add a medication with a different mode of action to bolster the effect of an antidepressant in cases of treatment resistance; a 2002 large community study of 244,859 depressed Veterans Administration patients found that 22% had received a second agent, most commonly a second antidepressant.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2231%22])">31</ref> Lithium has been used to augment antidepressant therapy in those who have failed to respond to antidepressants alone.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref> Furthermore, lithium dramatically decreases the suicide risk in recurrent depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2233%22])">33</ref> Addition of <link xlink:type="simple" xlink:href="../272/185272.xml">
atypical antipsychotic</link>s when the patient has not responded to an antidepressant is also known to increase the effectiveness of antidepressant drugs, albeit at the cost of more frequent side effects.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> There is some evidence for the addition of a thyroid hormone, <link xlink:type="simple" xlink:href="../048/467048.xml">
triiodothyronine</link>, in patients with normal thyroid function.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref></p>

</ss1>
<ss1>
<st>
 Efficacy of medication and psychotherapy </st>
<p>

Two recent <know-how wordnetid="105616786" confidence="0.8">
<method wordnetid="105660268" confidence="0.8">
<link xlink:type="simple" xlink:href="../329/62329.xml">
meta-analyses</link></method>
</know-how>
 of clinical trial results submitted to the FDA concluded that antidepressants are <link xlink:type="simple" xlink:href="../685/26685.xml">
statistically</link> superior to <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link> but their overall effect is low-to-moderate. In that respect they often did not exceed the <link xlink:type="simple" xlink:href="../680/429680.xml">
National Institute for Health and Clinical Excellence</link> criteria for a "clinically significant" effect. In particular, the effect size was very small for moderate depression but increased with severity reaching "clinical significance" for very severe depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref> These result were consistent with the earlier clinical studies in which only patients with severe depression benefited from either psychotherapy or treatment with an antidepressant, <link xlink:type="simple" xlink:href="../238/1019238.xml">
imipramine</link>, more than from the placebo treatment.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2239%22])">39</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref> Despite obtaining similar results, the authors argued about their interpretation. One author concluded that there "seems little evidence to support the prescription of antidepressant medication to any but the most severely
depressed patients, unless alternative treatments have failed to provide benefit."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref> The other author agreed that "antidepressant 'glass' is far from full" but disagreed "that it is completely empty". He pointed out that the first-line alternative to medication is psychotherapy, which does not have superior efficacy.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref> </p>
<p>

Antidepressants in general are as effective as psychotherapy for major depression, and this conclusion holds true for both severe and mild forms of MDD.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref> In contrast, medication gives better results for <link xlink:type="simple" xlink:href="../947/1295947.xml">
dysthymia</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref> The subgroup of SSRIs may be slightly more efficacious than psychotherapy. On the other hand, significantly more patients drop off from the antidepressant treatment than from psychotherapy, likely because of the side effects of antidepressants.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref> Successful psychotherapy appears to prevent the recurrence of depression even after it has been terminated or replaced by occasional "booster" sessions. The same degree of prevention can be achieved by continuing antidepressant treatment.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref></p>

</ss1>
</sec>
<sec>
<st>
 Electroconvulsive therapy </st>

<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../093/44093.xml">
Electroconvulsive therapy</link></it>
</indent>
Electroconvulsive therapy (ECT) is a treatment where <link xlink:type="simple" xlink:href="../154/27154.xml">
seizure</link>s are electrically induced in anesthetized patients for therapeutic effect. ECT is most often used as a "last resort" (from the perspective of hospital psychiatrists) for severe major depression which has not responded to trials of antidepressant or, less often, psychotherapy or supportive interventions.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref> It has a quicker effect than antidepressant therapy, and thus may be the treatment of choice in emergencies such as catatonic depression where the patient has ceased oral intake of fluid or nutrients, or where there is severe suicidality.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref> Some evidence suggests it is the most effective treatment for depression in the short-term<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2245%22])">45</ref> and one study, without a comparison group or assessment of additional treatments given, suggested that in the minority who remit it may be related to improved self-rated <link xlink:type="simple" xlink:href="../789/47789.xml">
quality of life</link> in both the short-term (which was correlated with the degree of amnesia) and after six months.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2246%22])">46</ref> However, the first systematic documentation of the effectiveness of ECT in community practice in the 65 years of its use found much lower <link xlink:type="simple" xlink:href="../477/324477.xml">
remission</link> rates than in prior research, and most of those relapsed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2247%22])">47</ref> ECT on its own does not usually have a sustained benefit, as virtually all those who remit end up relapsing within 6 months following a course, even when given a placebo.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2248%22])">48</ref> The relapse rate in the first six months may be reduced by the use of psychatric medications or further ECT (though the latter is not recommended by some authorities, such as NICE), but remains high.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2249%22])">49</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2250%22])">50</ref> <link xlink:type="simple" xlink:href="../944/28944.xml">
Short-term memory</link> loss, disorientation, headache and other <link xlink:type="simple" xlink:href="../961/1474961.xml">
adverse effects</link> are common, as are <link xlink:type="simple" xlink:href="../995/17995.xml">
long-term memory</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2251%22])">51</ref> and other neurocognitive deficits, which may persist. The <social_group wordnetid="107950920" confidence="0.8">
<society wordnetid="107966140" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<link xlink:type="simple" xlink:href="../911/160911.xml">
American Psychiatric Association</link></group>
</society>
</social_group>
 and the <link xlink:type="simple" xlink:href="../680/429680.xml">
National Institute for Health and Clinical Excellence</link> have concluded that the evidence they had suggested that the procedure, when administered according to their standards and without complications, does not cause <link xlink:type="simple" xlink:href="../588/304588.xml">
brain damage</link> in adults.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2252%22])">52</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2253%22])">53</ref></p>

</sec>
<sec>
<st>
Other conventional methods of treatment</st>

<ss1>
<st>
St John's wort</st>
<p>

<image location="right" width="150px" src="Hypericum_perforatum_plant_belair_park.jpg" type="thumb">
<caption>

St. John's Wort (<it><link xlink:type="simple" xlink:href="../555/183555.xml">
Hypericum perforatum</link></it>)
</caption>
</image>
</p>
<p>

<plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../555/183555.xml">
St John's wort</link></building_complex>
</artifact>
</structure>
</plant>
 extract is used extensively in Europe to treat mild and moderate depression. It is a prescription <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
antidepressant</link> in several European countries but is classified as an <link xlink:type="simple" xlink:href="../973/439973.xml">
herbal supplement</link> and sold over the counter in the U.S. Opinions on its efficacy  for major depression differ. A systematic <link xlink:type="simple" xlink:href="../329/62329.xml">
meta-analysis</link> of 37 trials conducted by <link xlink:type="simple" xlink:href="../721/237721.xml">
Cochrane Collaboration</link> indicated <link xlink:type="simple" xlink:href="../995/160995.xml">
statistically significant</link> weak-to-moderate effect as compared to <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link>. The same meta-analysis found that St John's wort efficacy for major depression is not different from prescription antidepressants.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2254%22])">54</ref> <link xlink:type="simple" xlink:href="../043/391043.xml">
NCCAM</link> and other <link xlink:type="simple" xlink:href="../174/46174.xml">
NIH</link>-affiliated organizations hold that St John's wort has minimal or no effects beyond placebo in the treatment of major depression, based primarily on one study with negative outcome conducted by NCCAM.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2255%22])">55</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2256%22])">56</ref></p>

</ss1>
<ss1>
<st>
SAM-e</st>
<p>

<link xlink:type="simple" xlink:href="../929/595929.xml">
S-Adenosyl methionine</link> (SAM-e) is available as a prescription antidepressant in <link xlink:type="simple" xlink:href="../239/9239.xml">
Europe</link> and an over-the-counter <link xlink:type="simple" xlink:href="../444/104444.xml">
dietary supplement</link> in the United States. Fairly strong evidence from 16 clinical trials suggests it to be more effective than placebo and as effective as standard antidepressant medication for the treatment of major depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2257%22])">57</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2258%22])">58</ref> <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2259%22])">59</ref></p>

</ss1>
<ss1>
<st>
Repetitive transcranial magnetic stimulation</st>
<p>

<link xlink:type="simple" xlink:href="../093/98093.xml">
Repetitive transcranial magnetic stimulation</link> (rTMS) use in treatment-resistant depression is supported by multiple controlled studies, and it has been approved for this indication in Europe, Canada and Australia, but not in the U.S. A 2008 meta-analysis based on 32 trials found a robust effect of this method on depression, and it appeared similarly effective for both uncomplicated depression and depression resistant to medication.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2260%22])">60</ref> However, it was inferior to ECT in a side-by-side randomized trial.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2261%22])">61</ref></p>

</ss1>
<ss1>
<st>
Vagus nerve stimulation</st>
<p>

<system wordnetid="104377057" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<link xlink:type="simple" xlink:href="../976/2326976.xml">
Vagus nerve stimulation</link></instrumentality>
</artifact>
</system>
 (VNS) uses an implanted electrode and generator to deliver electrical pulses to the vagus nerve, one of the primary nerves emanating from the brain.  It is an approved therapy for treatment-resistant depression and is sometimes used as an adjunct to existing antidepressant treatment. The support for this method comes mainly from open-label trials, which indicate that several months may be required to see a benefit. The only large double-blind trial conducted lasted only 10 weeks and yielded inconclusive results; VNS failed to show superiority over a sham treatment on the primary efficacy outcome, but the results were more favorable for the secondary outcome.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2262%22])">62</ref></p>

</ss1>
</sec>
<sec>
<st>
Alternative treatment methods</st>

<ss1>
<st>
Bright light therapy</st>

<p>

<indent level="1">

<it>Main article: <link>
Seasonal Affective Disorder</link></it>
</indent>
<image location="right" width="200px" src="Bright_light_lamp.jpg" type="thumb">
<caption>

Bright light therapy is sometimes used to treat depression, especially in its <link xlink:type="simple" xlink:href="../811/66811.xml">
seasonal form</link>.
</caption>
</image>

A meta-analysis of bright <link xlink:type="simple" xlink:href="../110/699110.xml">
light therapy</link> commissioned by the <social_group wordnetid="107950920" confidence="0.8">
<society wordnetid="107966140" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<link xlink:type="simple" xlink:href="../911/160911.xml">
American Psychiatric Association</link></group>
</society>
</social_group>
 found it to be more effective than placebo—usually, dim light—for both <link xlink:type="simple" xlink:href="../811/66811.xml">
seasonal affective disorder</link> and for nonseasonal depression, with effect sizes similar to those for conventional antidepressants. For non-seasonal depression, adding light therapy to the standard antidepressant treatment was not effective.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2263%22])">63</ref> A meta-analysis of light therapy for non-seasonal depression conducted by Cochrane Collaboration, studied a different set of trials, where light was used mostly as an addition to medication or <link xlink:type="simple" xlink:href="../893/18597893.xml">
sleep deprivation</link>. A moderate statistically significant effect of light therapy was found; however, it disappeared if a different statistical technique was used.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2264%22])">64</ref> Both analyses noted poor quality of most studies and their small size, and urged caution in the interpretation of their results. The short 1-2 weeks duration of most trials makes it unclear whether the effect of light therapy could be sustained in the longer term.</p>

</ss1>
<ss1>
<st>
Acupuncture</st>
<p>

A 2004 <link xlink:type="simple" xlink:href="../721/237721.xml">
Cochrane Review</link> concluded that based on the low quality of the evidence base there is "insufficient evidence to determine whether acupuncture is effective in the management of depression."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2265%22])">65</ref></p>

</ss1>
<ss1>
<st>
Exercise</st>
<p>

<link xlink:type="simple" xlink:href="../037/189037.xml">
Exercise</link>, when used in conjunction with medication by non-suicidal patients, can have beneficial effects in preventing the return of depression. Patients who completed 30 minutes of brisk exercise at least three times a week were found to have a significantly lower incidence of relapse.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2266%22])">66</ref></p>
<p>

Vigorous exercise has significant physiological effects which help to reduce stress and counter depression.  Also, by improving fitness and self-esteem, exercise may enable the sufferer to cope better with demanding events and situations and so reduce the likelihood of depressing failure.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2267%22])">67</ref></p>
<p>

Exercise in natural surroundings such as the <link xlink:type="simple" xlink:href="../614/212614.xml">
countryside</link> or <link xlink:type="simple" xlink:href="../459/166459.xml">
park</link>s is especially recommended because contact with nature and green spaces has a positive effect upon mental health.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2268%22])">68</ref> <link xlink:type="simple" xlink:href="../984/11984.xml">
Gardening</link> is an ideal activity of this sort, providing mental, practical and social benefits.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2269%22])">69</ref></p>

</ss1>
<ss1>
<st>
Deep Brain Stimulation</st>
<p>

The support for the use of <link xlink:type="simple" xlink:href="../268/370268.xml">
deep brain stimulation</link> in <link xlink:type="simple" xlink:href="../273/3440273.xml">
treatment-resistant depression</link> comes from a handful of case studies, and this treatment is still in a very early investigational stage.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2270%22])">70</ref></p>

</ss1>
<ss1>
<st>
Tryptophan</st>
<p>

<link xlink:type="simple" xlink:href="../358/58358.xml">
Tryptophan</link> and <link xlink:type="simple" xlink:href="../579/822579.xml">
5-hydroxytryptophan</link> may be more effective than placebo in alleviating depression according to the Cochrane Collaboration meta-analysis. However, only two out of 108 trials were of sufficient quality to be included in this analysis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2271%22])">71</ref></p>
<p>

<link xlink:type="simple" xlink:href="../358/58358.xml">
Tryptophan</link> is the precursor of the <link xlink:type="simple" xlink:href="../865/21865.xml">
neurotransmitter</link> <link xlink:type="simple" xlink:href="../764/28764.xml">
serotonin</link>. It has shown some promise as an <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
antidepressant</link> alone<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2272%22])">72</ref> and as an augmenter of <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
antidepressant</link> drugs.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2272%22])">72</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2273%22])">73</ref> Foods rich in tryptophan include bananas, chickpeas, chocolate, cottage cheese, dates, eggs, fish, oats, mangoes, milk, peanuts, poultry, pumpkin seeds, red meat, sesame, spirulina, sunflower seeds and yogurt.</p>

</ss1>
<ss1>
<st>
Omega-3 fatty acids</st>
<p>

<image location="right" width="150px" src="Flax_seeds.jpg" type="thumb">
</image>

<link xlink:type="simple" xlink:href="../594/22594.xml">
Omega-3 fatty acid</link>s have been studied in clinical trials for major depression primarily as an adjunctive to antidepressant therapy. A meta-analysis of eight such trials indicated a statistically significant superiority of combinations with omega-3 fatty acids over single antidepressants; however, the authors warned that, due to multiple problems with these trials, a reliable conclusion is difficult to achieve.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2274%22])">74</ref></p>
<p>

<link>
Omega-3 fatty acids</link> have been shown to help many people with depression, the theory being that Omega-3 helps nourish brain cells that release serotonin into the brain.  Omega-3 fatty acids are present, for example, in cold-water fish such as <link xlink:type="simple" xlink:href="../984/36984.xml">
salmon</link>, in <link xlink:type="simple" xlink:href="../869/38869.xml">
flax</link> seed, in <link xlink:type="simple" xlink:href="../306/999306.xml">
fish oil</link> capsules and in flax seed capsules.</p>
<p>

"Several epidemiological studies suggest covariation between seafood consumption and rates of mood disorders. Biological marker studies indicate deficits in omega-3 fatty acids in people with depressive disorders, while several treatment studies indicate therapeutic benefits from omega-3 supplementation. A similar contribution of omega-3 fatty acids to coronary artery disease may explain the well-described links between coronary artery disease and depression. Deficits in omega-3 fatty acids have been identified as a contributing factor to mood disorders and offer a potential rational treatment approach." (American Journal of Psychiatry 163:969-978, June 2006)<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2275%22])">75</ref></p>

</ss1>
<ss1>
<st>
DHEA</st>
<p>

<link xlink:type="simple" xlink:href="../807/8807.xml">
Dehydroepiandrosterone</link> (DHEA), a metabolic precursor for several hormones including estrogen and testosterone, has been promoted as a remedy for many ailments. Sold in the 1970s and 1980s as a weight-loss aid, it was subsequently banned for over-the-counter sale, but then unbanned, and is currently available as a supplement in the US. It has been shown to be more effective than placebo in two small double-blind trials: in one as an adjunct to antidepressant treatment,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2276%22])">76</ref> and as monotherapy in another.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2277%22])">77</ref></p>

</ss1>
<ss1>
<st>
Chromium picolinate</st>
<p>

<link xlink:type="simple" xlink:href="../898/2876898.xml">
Chromium picolinate</link> was found to be equivalent to placebo for <link xlink:type="simple" xlink:href="../697/2367697.xml">
atypical depression</link> overall but possibly efficacious in the sub-group of patients with severe carbohydrate craving.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2278%22])">78</ref></p>

</ss1>
<ss1>
<st>
Zinc</st>
<p>

<link xlink:type="simple" xlink:href="../420/34420.xml">
Zinc</link> supplementation was found in a small study to augment the effect of antidepressants.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2279%22])">79</ref></p>
<p>

Serum levels of <link xlink:type="simple" xlink:href="../420/34420.xml">
zinc</link> are found to be low in depressed patients and supplementation with zinc has been demonstrated to be of benefit.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2280%22])">80</ref> Zinc is found in beans, meat, nuts, oysters, whole grains and seeds.</p>

</ss1>
<ss1>
<st>
Cranial electrotherapy stimulation</st>
<p>

<work wordnetid="100575741" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../716/493716.xml">
Cranial electrotherapy stimulation</link></activity>
</psychological_feature>
</act>
</care>
</event>
</treatment>
</work>
 (CES, electrosleep) devices currently on the market have been granted marketing authorization by the FDA based on the legacy waver, that is because a sufficiently similar device had been marketed before 1976, when the new regulations requiring controlled testing were introduced.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2281%22])">81</ref> The FDA considers them to be the class III devices—"devices for which insufficient information exists to ... provide reasonable assurance of safety and effectiveness"<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2282%22])">82</ref> The effects of CES on depression were inconclusive or negative in multiple double-blind studies of psychiatric patients.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2283%22])">83</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2284%22])">84</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2285%22])">85</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2286%22])">86</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2284%22])">84</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2287%22])">87</ref> In one of them, four out of six clinically depressed patients dropped out of the study because of the massive worsening of depressive symptoms, with two of them becoming actively suicidal.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2287%22])">87</ref> One of the authors of the latter study cautioned that CES “should not be used as a treatment of choice” for the patients with the primary diagnosis of depression, “and should be used with caution if this diagnosis is suspected.”<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2288%22])">88</ref> Nevertheless, the CES practitioners continue to employ it as a treatment of choice for depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2289%22])">89</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2290%22])">90</ref></p>

</ss1>
<ss1>
<st>
Eleuthero</st>
<p>

<it><link xlink:type="simple" xlink:href="../507/1214507.xml">
Eleutherococcus senticosus</link></it> is used in <link xlink:type="simple" xlink:href="../992/5992.xml">
Traditional Chinese Medicine</link> and is now used in the West as Eleuthero or Siberian Ginseng.  The plant is an <link xlink:type="simple" xlink:href="../947/1939947.xml">
adaptogen</link> or <link xlink:type="simple" xlink:href="../709/231709.xml">
tonic</link> and has been shown to have significant antidepressant effects in rats.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2291%22])">91</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2292%22])">92</ref></p>

</ss1>
<ss1>
<st>
Inositol</st>

<p>

<link xlink:type="simple" xlink:href="../807/866807.xml">
Inositol</link> has been shown through various studies to be an effective treatment for depression, bipolar disorder, <link xlink:type="simple" xlink:href="../393/54393.xml">
obsessive-compulsive disorder</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2293%22])">93</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2294%22])">94</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2295%22])">95</ref> and panic attacks.</p>

</ss1>
<ss1>
<st>
Saffron</st>

<p>

Saffron, the flowers of <it><link xlink:type="simple" xlink:href="../332/53332.xml">
Crocus sativus</link></it> have been shown to have antidepressant properties.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2296%22])">96</ref>  Two of the active ingredients are <link xlink:type="simple" xlink:href="../481/3608481.xml">
crocin</link> and <link xlink:type="simple" xlink:href="../604/3409604.xml">
safranal</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2296%22])">96</ref></p>

</ss1>
<ss1>
<st>
Minerals</st>
<p>

In the late 1800s there was a vogue for consumption of <link xlink:type="simple" xlink:href="../772/9621772.xml">
lithia water</link> which contained a significant quantity of <link xlink:type="simple" xlink:href="../561/17561.xml">
lithium</link>.  Some claimed that this cured depression, but its effectiveness is not clear.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2297%22])">97</ref></p>
<p>

<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../057/3029057.xml">
Magnesium deficiency</link></disease>
 is common and may cause depression.  Supplementation or changes in diet may therefore be helpful.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2298%22])">98</ref>  Foodstuffs rich in <link xlink:type="simple" xlink:href="../909/18909.xml">
magnesium</link> include include whole grains, beans and seeds, halibut and spinach.</p>

</ss1>
<ss1>
<st>
Vitamin B8</st>

<p>

<link xlink:type="simple" xlink:href="../807/866807.xml">
Inositol</link> or vitamin B8 is found in cereals with high bran content, nuts, beans, and fruit, especially cantaloupe melons and oranges.  It has been shown to be an effective treatment for depression, bipolar disorder and <link xlink:type="simple" xlink:href="../393/54393.xml">
obsessive-compulsive disorder</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2299%22])">99</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22100%22])">100</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22101%22])">101</ref> and panic attacks.  The therapeutic dosage of inositol seems to be between 6-20 g/day, with 12-18 g/day being more likely an effective dosage.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22102%22])">102</ref></p>

</ss1>
<ss1>
<st>
Kanna</st>

<p>

<image location="right" width="150px" src="Sceletium_tortuosum_01102003_Afrique_du_sud_2.JPG" type="thumb">
<caption>

Kanna (<it><plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../973/4339973.xml">
Sceletium tortuosum</link></building_complex>
</artifact>
</structure>
</plant>
</it>) plant
</caption>
</image>
</p>
<p>

<link xlink:type="simple" xlink:href="../677/976677.xml">
Kanna</link> (<it>Sceletium tortuosum</it>) is a succulent herb commonly found in South Africa.  In doses as low as 50 mg, users have reported improvements in mood, decreased anxiety, relaxation and a sense of well-being. It contains about 1-1.5% <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
alkaloid</link>s and those which are believed to be <link xlink:type="simple" xlink:href="../887/87887.xml">
psychoactive</link> include <link xlink:type="simple" xlink:href="../894/8663894.xml">
mesembrine</link>, <link>
mesembrenone</link>, <link>
mesembrenol</link> and <link>
tortuosamine</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22103%22])">103</ref> </p>
<p>

There is about 0.3% mesembrine in the leaves and 0.86% in the stems of the plant.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22104%22])">104</ref> This has been shown to be a potent <link xlink:type="simple" xlink:href="../385/12859385.xml">
serotonin reuptake inhibitor</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22105%22])">105</ref></p>

</ss1>
<ss1>
<st>
Flower remedies</st>
<p>

<work wordnetid="100575741" confidence="0.8">
<group_action wordnetid="101080366" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<intervention wordnetid="101240210" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<medical_care wordnetid="100657604" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<therapy wordnetid="100661091" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<engagement wordnetid="101239064" confidence="0.8">
<link xlink:type="simple" xlink:href="../615/185615.xml">
Bach flower remedies</link></engagement>
</activity>
</psychological_feature>
</therapy>
</act>
</medical_care>
</care>
</event>
</intervention>
</treatment>
</group_action>
</work>
 and <link xlink:type="simple" xlink:href="../991/16742991.xml">
Australian bush flower essences</link> are <link xlink:type="simple" xlink:href="../229/14229.xml">
homeopathic remedies</link> prepared from various flowers. Current clinical evidence does not support any hypothesized action or efficacy beyond <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link> effects.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22106%22])">106</ref></p>
<p>

Four <it>Bach flower remedies</it> are described in connection with depression: <b><link xlink:type="simple" xlink:href="../003/58003.xml">
gentian</link></b> for very mild depression or pessimism; <b><link xlink:type="simple" xlink:href="../346/448346.xml">
gorse</link></b> for more serious depression; <b><link xlink:type="simple" xlink:href="../956/437956.xml">
sweet chestnut</link></b> for severe depression; and <b><plant wordnetid="103956922" confidence="0.8">
<solid wordnetid="115046900" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<food wordnetid="107555863" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<vegetable wordnetid="107707451" confidence="0.8">
<produce wordnetid="107705711" confidence="0.8">
<link xlink:type="simple" xlink:href="../368/2028368.xml">
mustard</link></produce>
</vegetable>
</building_complex>
</food>
</artifact>
</structure>
</solid>
</plant>
</b> for depression that comes from within and is not related to external circumstances.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22107%22])">107</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22108%22])">108</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22109%22])">109</ref> Two <it>Australian bush flower essences</it> are described in connection with depression: <b><link xlink:type="simple" xlink:href="../969/1196969.xml">
waratah</link></b> for depression; and <b><link xlink:type="simple" xlink:href="../512/9421512.xml">
Sunshine Wattle</link></b> for pessimism and defeatism, especially after a long run of bad luck.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22110%22])">110</ref></p>

</ss1>
<ss1>
<st>
Potassium phosphate</st>

<p>

The <link xlink:type="simple" xlink:href="../229/14229.xml">
homeopathic dilution</link> of <link xlink:type="simple" xlink:href="../028/8527028.xml">
potassium phosphate</link>) is claimed to bring some short-term relief to depressed patients.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22111%22])">111</ref></p>

</ss1>
<ss1>
<st>
Meditation</st>

<p>

<link xlink:type="simple" xlink:href="../062/20062.xml">
Meditation</link> has been shown to be of benefit in a number of ways, including lowering blood pressure and stress levels. The most helpful and gentle form of meditation for a clinically depressed person may be the repetition&mdash;silently or aloud&mdash;of a <link xlink:type="simple" xlink:href="../367/197367.xml">
mantra</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22112%22])">112</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22113%22])">113</ref></p>

</ss1>
<ss1>
<st>
Neurofeedback</st>
<p>

<process wordnetid="105701363" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<instrumentality wordnetid="103575240" confidence="0.8">
<inquiry wordnetid="105797597" confidence="0.8">
<thinking wordnetid="105770926" confidence="0.8">
<problem_solving wordnetid="105796750" confidence="0.8">
<experiment wordnetid="105798043" confidence="0.8">
<device wordnetid="103183080" confidence="0.8">
<trial wordnetid="105799212" confidence="0.8">
<higher_cognitive_process wordnetid="105770664" confidence="0.8">
<link xlink:type="simple" xlink:href="../370/510370.xml">
Neurofeedback</link></higher_cognitive_process>
</trial>
</device>
</experiment>
</problem_solving>
</thinking>
</inquiry>
</instrumentality>
</artifact>
</process>
 is a form of <link xlink:type="simple" xlink:href="../906/292906.xml">
biofeedback</link> therapy in which brain activity is monitored using an <link xlink:type="simple" xlink:href="../647/153647.xml">
EEG</link>.  The output is presented to the patient who is then able to see any variation in the <link xlink:type="simple" xlink:href="../647/153647.xml">
brain wave</link>s associated with depression and may then develop some ability to reduce them, so improving their mood.  The resulting direct control of mental state is thought to be similar to that achieved by the mental exercises of <link xlink:type="simple" xlink:href="../258/34258.xml">
yoga</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22114%22])">114</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22115%22])">115</ref></p>

</ss1>
<ss1>
<st>
Reiki</st>
<p>

<work wordnetid="100575741" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<medical_care wordnetid="100657604" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<therapy wordnetid="100661091" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../329/166329.xml">
Reiki</link></activity>
</psychological_feature>
</therapy>
</act>
</medical_care>
</care>
</event>
</treatment>
</work>
 is a form of <link xlink:type="simple" xlink:href="../403/6913403.xml">
energy medicine</link> originated in 1922 by <link>
Mikao Usui</link>. A 2008 <link xlink:type="simple" xlink:href="../579/2994579.xml">
systematic review</link> of the current scientific research concluded that any recommendation of Reiki for the management of depression is not evidence-based.</p>

</ss1>
<ss1>
<st>
Religion</st>
<p>

Numerous studies and clinical trials have looked at the relationship between <link xlink:type="simple" xlink:href="../414/25414.xml">
religion</link> and <link xlink:type="simple" xlink:href="../460/90460.xml">
depression</link>.  These have looked at the matter from <link xlink:type="simple" xlink:href="../529/3267529.xml">
Buddhist</link>, <link xlink:type="simple" xlink:href="../522/18337522.xml">
Christian</link> and <link xlink:type="simple" xlink:href="../541/19541.xml">
Muslim</link> perspectives.  These indicate that religious faith helps to prevent the onset of depression and assists recovery if depression should still occur.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22116%22])">116</ref></p>

</ss1>
<ss1>
<st>
Sleep</st>
<p>

Depression is commonly associated with poor sleep - difficulty going to sleep, early waking and general lassitude during the day.  The two interact to worsen the condition of each other.  Good <link xlink:type="simple" xlink:href="../981/1268981.xml">
sleep hygiene</link> is therefore important to help break this vicious circle.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22117%22])">117</ref>  This would include measures such as regular bed times, avoidance of stimulants such as <link xlink:type="simple" xlink:href="../868/6868.xml">
caffeine</link> and management of disturbances such as <link xlink:type="simple" xlink:href="../445/28445.xml">
sleep apnea</link>.</p>

</ss1>
<ss1>
<st>
Chi Kung</st>
<p>

The traditional Chinese exercise of <link xlink:type="simple" xlink:href="../371/42371.xml">
Chi Kung</link> and related martial arts such as <link xlink:type="simple" xlink:href="../819/264819.xml">
Tai Chi</link> can help to prevent and relieve depression.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22118%22])">118</ref></p>

</ss1>
</sec>
<sec>
<st>
References</st>

<p>

<reflist>
<entry id="1">
"<weblink xlink:type="simple" xlink:href="http://www.beyondblue.org.au">
Beyond Blue</weblink>".&#32;Retrieved on <link>
2007-04-30</link>.</entry>
<entry id="2">
 <cite style="font-style:normal" class="book">NICE&#32;(2005). <weblink xlink:type="simple" xlink:href="http://www.nice.org.uk/Guidance/CG28/QuickRefGuide/pdf/English">
NICE guidelines: Depression in children and adolescents</weblink>.&#32;London:&#32;NICE,&#32;p. 5. ISBN 1-84629-074-0. Retrieved on <link>
2008-08-16</link>.</cite>&nbsp;</entry>
<entry id="3">
 <cite style="font-style:normal">Thase, ME&#32;(1999).&#32;"When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?". <it>Psychiatric Quarterly</it>&#32;<b>70</b>&#32;(4): 333–46. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1023%2FA%3A1022042316895">
10.1023/A:1022042316895</weblink>. PMID 10587988.</cite>&nbsp;</entry>
<entry id="4">
 <cite id="Reference-Roth-2005" style="font-style:normal" class="book">Roth, Anthony;&#32;Fonagy, Peter&#32;[1996]&#32;(2005). What Works for Whom? Second Edition: A Critical Review of Psychotherapy Research.&#32;Guilford Press,&#32;p. 78. ISBN 159385272X.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">March J, Silva S, Petrycki S, et al.&#32;(August 2004).&#32;"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../941/541941.xml">
JAMA</link></periodical>
</it>&#32;<b>292</b>&#32;(7): 807–20. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.292.7.807">
10.1001/jama.292.7.807</weblink>. PMID 15315995.</cite>&nbsp;</entry>
<entry id="6">
 <cite style="font-style:normal">Goodyer I, Dubicka B, Wilkinson P, et al.&#32;(July 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1925185">
Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: Randomised controlled trial</weblink>". <it>British Medical Journal</it>&#32;<b>335</b>&#32;(7611): 142. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.39224.494340.55">
10.1136/bmj.39224.494340.55</weblink>. PMID 17556431.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal">Goodyer IM, Dubicka B, Wilkinson P, et al.&#32;(May 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://www.hta.ac.uk/execsumm/summ1214.htm">
A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial</weblink>". <it>Health Technol Assess</it>&#32;<b>12</b>&#32;(14): 1–80. PMID 18462573.</cite>&nbsp;</entry>
<entry id="8">
 <cite style="font-style:normal">Domino ME, Burns BJ, Silva SG, et al.&#32;(May 2008).&#32;"Cost-effectiveness of treatments for adolescent depression: results from TADS". <it>American Journal of Psychiatry</it>&#32;<b>165</b>&#32;(5): 588–96. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.2008.07101610">
10.1176/appi.ajp.2008.07101610</weblink>. PMID 18413703.</cite>&nbsp;</entry>
<entry id="9">
 <cite style="font-style:normal">Coelho HF, Canter PH, Ernst E&#32;(December 2007).&#32;"Mindfulness-based cognitive therapy: evaluating current evidence and informing future research". <it>Journal of Consulting and Clinical Psychology</it>&#32;<b>75</b>&#32;(6): 1000–05. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1037%2F0022-006X.75.6.1000">
10.1037/0022-006X.75.6.1000</weblink>. PMID 18085916.</cite>&nbsp;</entry>
<entry id="10">
 <cite style="font-style:normal" class="book">Weissman MM, Markowitz JC, Klerman GL&#32;(2000). Comprehensive Guide to Interpersonal Psychotherapy.&#32;New York:&#32;Basic Books. ISBN 0-465-09566-6.</cite>&nbsp;</entry>
<entry id="11">
 <cite style="font-style:normal" class="book">Dworetzky J&#32;(1997). Psychology.&#32;Pacific Grove, CA, USA:&#32;Brooks/Cole Pub. Co,&#32;602. ISBN 0-314-20412-1.</cite>&nbsp;</entry>
<entry id="12">
 <cite style="font-style:normal">Doidge N, Simon B, Lancee WJ, et al.&#32;(2002).&#32;"Psychoanalytic patients in the US, Canada, and Australia: II. A DSM-III-R validation study". <it>Journal of the American Psychoanalytic Association</it>&#32;<b>50</b>&#32;(2): 615–27. PMID 12206545.</cite>&nbsp;</entry>
<entry id="13">
 <cite style="font-style:normal" class="book">Durand VM, Barlow D&#32;(1999). Abnormal psychology: An integrative approach.&#32;Pacific Grove, CA, USA:&#32;Brooks/Cole Pub. Co. ISBN 0-534-34742-8.</cite>&nbsp;</entry>
<entry id="14">
 <cite style="font-style:normal">de Maat S, Dekker J, Schoevers R, et al.&#32;(June 2007).&#32;"Short Psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: A mega-analysis based on three Randomized Clinical Trials". <it>Depression and Anxiety</it>&#32;<b>25</b>: 565. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fda.20305">
10.1002/da.20305</weblink>. PMID 17557313.</cite>&nbsp;</entry>
<entry id="15">
Depression Guideline Panel. Depression in primary care. Vol. 2. Treatment of major depression. Clinical practice guideline. No. 5. Rockville, MD: Agency for Health Care Policy and Research, 1999.</entry>
<entry id="17">
 <cite style="font-style:normal">Sutherland JE, Sutherland SJ, Hoehns JD&#32;(March 2003).&#32;"<weblink xlink:type="simple" xlink:href="http://www.jfponline.com/Pages.asp?AID=1406">
Achieving the best outcome in treatment of depression</weblink>". <it>Journal of Family Practice</it>&#32;<b>52</b>&#32;(3): 201–09. PMID 12620174.</cite>&nbsp;</entry>
<entry id="16">
Mayo Clinic Staff&#32;(2006-03-06).&#32;"<weblink xlink:type="simple" xlink:href="http://www.nimh.nih.gov/health/publications/depression/nimhdepression.pdf">
Depression</weblink>".&#32;  <agency wordnetid="108337324" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../909/455909.xml">
National Institute of Mental Health</link></agency>
 (NIMH).&#32;Retrieved on <link>
2007-10-20</link>.</entry>
<entry id="19">
 <cite style="font-style:normal">Rush AJ, Trivedi MH, Wisniewski SR, et al.&#32;(2006).&#32;"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression". <it>New England Journal of Medicine</it>&#32;<b>354</b>&#32;(12): 1231–42. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMoa052963">
10.1056/NEJMoa052963</weblink>. PMID 16554525.</cite>&nbsp;</entry>
<entry id="18">
 <cite style="font-style:normal">Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB&#32;(2006).&#32;"Use of bupropion in combination with serotonin reuptake inhibitors". <it>Biological Psychiatry</it>&#32;<b>59</b>&#32;(3): 203–10. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2005.06.027">
10.1016/j.biopsych.2005.06.027</weblink>. PMID 16165100.</cite>&nbsp;</entry>
<entry id="21">
 <cite style="font-style:normal">Mayers AG, Baldwin DS&#32;(December 2005).&#32;"Antidepressants and their effect on sleep". <it>Human Psychopharmacology</it>&#32;<b>20</b>&#32;(8): 533–59. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fhup.726">
10.1002/hup.726</weblink>. PMID 16229049.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ&#32;(2006).&#32;"Medication augmentation after the failure of SSRIs for depression". <it>New England Journal of Medicine</it>&#32;<b>354</b>&#32;(12): 1243–52. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMoa052964">
10.1056/NEJMoa052964</weblink>. PMID 16554526.</cite>&nbsp;</entry>
<entry id="23">
 <cite style="font-style:normal">Lawrence RW&#32;(August 2004).&#32;"<weblink xlink:type="simple" xlink:href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10001013">
Effect of mirtazapine versus fluoxetine on "sleep quality"</weblink>". <it>Journal of Clinical Psychiatry</it>&#32;<b>65</b>&#32;(8): 1149–50. PMID 15323610.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">Winokur A, DeMartinis NA, McNally DP, Gary EM, Cormier JL, Gary KA&#32;(October 2003).&#32;"Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia". <it>Journal of Clinical Psychiatry</it>&#32;<b>64</b>&#32;(10): 1224–29. PMID 14658972.</cite>&nbsp;</entry>
<entry id="25">
 <cite style="font-style:normal">Cipriani A, Geddes JR, Barbui C&#32;(2007).&#32;"<weblink xlink:type="simple" xlink:href="http://www.bmj.com/cgi/content/full/334/7587/215?grp=1">
Venlafaxine for major depression</weblink>". <it>British Medical Journal</it>&#32;<b>334</b>: p. 215 (editorial). <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.39098.457720.BE">
10.1136/bmj.39098.457720.BE</weblink>. Retrieved on <link>
2008-09-13</link>.</cite>&nbsp;</entry>
<entry id="24">
 <cite style="font-style:normal">Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC&#32;(December 2007).&#32;"Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents". <it>Biological Psychiatry</it>&#32;<b>62</b>&#32;(11): 1217–27. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2007.03.027">
10.1016/j.biopsych.2007.03.027</weblink>. PMID 17588546.</cite>&nbsp;</entry>
<entry id="27">
"<weblink xlink:type="simple" xlink:href="http://www.nice.org.uk/Guidance/CG28">
Depression in children and young people: identification and management in primary, community and secondary care</weblink>".&#32;  NHS National Institute for Health and Clinical Excellence&#32;(September 2005).&#32;Retrieved on <link>
2008-08-17</link>.</entry>
<entry id="26">
"<weblink xlink:type="simple" xlink:href="http://www.nice.org.uk/Guidance/CG28">
Depression in children and young people: identification and management in primary, community and secondary care</weblink>".&#32;  NHS National Institute for Health and Clinical Excellence&#32;(September 2005).&#32;Retrieved on <link>
2008-08-17</link>.</entry>
<entry id="29">
 <cite style="font-style:normal">Anderson IM&#32;(April 2000).&#32;"<weblink xlink:type="simple" xlink:href="http://linkinghub.elsevier.com/retrieve/pii/S0165-0327(99)00092-0">
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability</weblink>". <it>Journal of Affective Disorders</it>&#32;<b>58</b>&#32;(1): 19–36. PMID 10760555.</cite>&nbsp;</entry>
<entry id="28">
 <cite style="font-style:normal">Anderson IM&#32;(1998).&#32;"SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability". <it>Depression and Anxiety</it>&#32;<b>7 Suppl 1</b>: 11–17. PMID 9597346.</cite>&nbsp;</entry>
<entry id="31">
 <cite style="font-style:normal">Valenstein M, McCarthy JF, Austin KL, Greden JF, Young EA, Blow FC&#32;(2006).&#32;"What happened to lithium? Antidepressant augmentation in clinical settings". <it>American Journal of Psychiatry</it>&#32;<b>163</b>&#32;(7): 1219–25. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.163.7.1219">
10.1176/appi.ajp.163.7.1219</weblink>. PMID 16816227.</cite>&nbsp;</entry>
<entry id="30">
 <cite style="font-style:normal">Krishnan KR&#32;(2007).&#32;"<weblink xlink:type="simple" xlink:href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10003141">
Revisiting monoamine oxidase inhibitors</weblink>". <it>Journal of Clinical Psychiatry</it>&#32;<b>68 Suppl 8</b>: 35–41. PMID 17640156.</cite>&nbsp;</entry>
<entry id="34">
Bender KJ&#32;(2008-02-01).&#32;"<weblink xlink:type="simple" xlink:href="http://www.psychiatrictimes.com/display/article/10168/1147436">
Evidence Grows for Value of Antipsychotics as Antidepressant Adjuncts - Psychiatric Times</weblink>"&#32;(htm).&#32;  Psychiatric Times.&#32;Retrieved on <link>
2008-08-06</link>.</entry>
<entry id="35">
 <cite style="font-style:normal">Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ&#32;(2006).&#32;"A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report". <it>American Journal of Psychiatry</it>&#32;<b>163</b>&#32;(9): 1519–30. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.163.9.1519">
10.1176/appi.ajp.163.9.1519</weblink>. PMID 16946176.</cite>&nbsp;</entry>
<entry id="32">
 <cite style="font-style:normal">Bauer M, Dopfmer S&#32;(1999).&#32;"Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies". <it>Journal of Clinical Psychopharmacology</it>&#32;<b>19</b>&#32;(5): 427–34. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1097%2F00004714-199910000-00006">
10.1097/00004714-199910000-00006</weblink>. PMID 10505584.</cite>&nbsp;</entry>
<entry id="33">
 <cite style="font-style:normal">Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ&#32;(March 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10002980">
Lithium treatment reduces suicide risk in recurrent major depressive disorder</weblink>". <it>J Clin Psychiatry</it>&#32;<b>68</b>&#32;(3): 380–83. PMID 17388706.</cite>&nbsp;</entry>
<entry id="38">
 <cite style="font-style:normal">Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP&#32;(1989).&#32;"National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments". <it>Archives of General Psychiatry</it>&#32;<b>46</b>&#32;(11): 971–82; discussion 983. PMID 2684085.</cite>&nbsp;</entry>
<entry id="39">
 <cite style="font-style:normal">Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D&#32;(1995).&#32;"Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program". <it>Journal of Consulting and Clinical Psychology</it>&#32;<b>63</b>&#32;(5): 841–47. PMID 7593878.</cite>&nbsp;</entry>
<entry id="36">
 <cite style="font-style:normal">Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT&#32;(February 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045&amp;ct=1">
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration</weblink>". <it>PLoS Med.</it>&#32;<b>5</b>&#32;(2): e45. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1371%2Fjournal.pmed.0050045">
10.1371/journal.pmed.0050045</weblink>. PMID 18303940. <link xlink:type="simple" xlink:href="../325/2775325.xml">
PMC</link>:<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2253608">
2253608</weblink>.</cite>&nbsp;</entry>
<entry id="37">
 <cite style="font-style:normal">Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R&#32;(January 2008).&#32;"Selective publication of antidepressant trials and its influence on apparent efficacy". <it>N. Engl. J. Med.</it>&#32;<b>358</b>&#32;(3): 252–60. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMsa065779">
10.1056/NEJMsa065779</weblink>. PMID 18199864.</cite>&nbsp;</entry>
<entry id="42">
 <cite style="font-style:normal">Cuijpers P, van Straten A, van Oppen P, Andersson G&#32;(August 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://www.psychiatrist.com/abstracts/abstracts.asp?abstract=oap/ej08r04112.htm">
Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders? A Meta-Analysis of Comparative Studies</weblink>". <it>Journal of Clinical Psychiatry</it>: e1–e11.</cite>&nbsp;</entry>
<entry id="43">
 <cite style="font-style:normal">Imel ZE, Malterer MB, McKay KM, Wampold BE&#32;(October 2008).&#32;"A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia". <it>J Affect Disord</it>&#32;<b>110</b>&#32;(3): 197–206. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.jad.2008.03.018">
10.1016/j.jad.2008.03.018</weblink>. PMID 18456340.</cite>&nbsp;</entry>
<entry id="40">
 <cite style="font-style:normal">Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J&#32;(1991).&#32;"Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program". <it>American Journal of Psychiatry</it>&#32;<b>148</b>&#32;(8): 997–1008. PMID 1853989.</cite>&nbsp;</entry>
<entry id="41">
 <cite style="font-style:normal">Turner EH, Rosenthal R&#32;(March 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2265347">
Efficacy of antidepressants</weblink>". <it>BMJ</it>&#32;<b>336</b>&#32;(7643): 516–7. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.39510.531597.80">
10.1136/bmj.39510.531597.80</weblink>. PMID 18319297.</cite>&nbsp;</entry>
<entry id="46">
 <cite style="font-style:normal">McCall WV, Prudic J, Olfson M, Sackeim H&#32;(February 2006).&#32;"Health-related quality of life following ECT in a large community sample". <it>Journal of Affective Disorders</it>&#32;<b>90</b>&#32;(2–3): 69–74. PMID 16412519.</cite>&nbsp;</entry>
<entry id="47">
 <cite style="font-style:normal">Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA&#32;(2004).&#32;"Effectiveness of electroconvulsive therapy in community settings". <it>Biol. Psychiatry</it>&#32;<b>55</b>&#32;(3): 301–12. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2003.09.015">
10.1016/j.biopsych.2003.09.015</weblink>. PMID 14744473.</cite>&nbsp;</entry>
<entry id="44">
 <cite style="font-style:normal"><social_group wordnetid="107950920" confidence="0.8">
<society wordnetid="107966140" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<link xlink:type="simple" xlink:href="../911/160911.xml">
American Psychiatric Association</link></group>
</society>
</social_group>
&#32;(April 2000).&#32;"<weblink xlink:type="simple" xlink:href="http://www.guideline.gov/summary/summary.aspx?doc_id=2605#s23">
Practice guideline for the treatment of patients with major depressive disorder</weblink>". <it>American Journal of Psychiatry</it>&#32;<b>157</b>&#32;(Supp 4): 1–45. PMID 10767867.</cite>&nbsp;</entry>
<entry id="45">
 <cite style="font-style:normal">The UK ECT Review Group&#32;(2003).&#32;"<weblink xlink:type="simple" xlink:href="http://linkinghub.elsevier.com/retrieve/pii/S0140673603127055">
Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis</weblink>". <it>The Lancet</it>&#32;<b>361</b>&#32;(9360): 799–808.</cite>&nbsp;</entry>
<entry id="51">
<link xlink:type="simple" xlink:href="#xpointer(//cite[@id=%22CITEREFBarlow2005%22])">
Barlow 2005</link>, p.&nbsp;239</entry>
<entry id="50">
Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al. (2006) Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006 Dec;63(12):1337-44. PMID 17146008</entry>
<entry id="49">
Tew JD Jr, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA. (2007) Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment] Ann Clin Psychiatry. 2007 Jan-Mar;19(1):1-4 PMID 17453654</entry>
<entry id="48">
Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J.(2001) <weblink xlink:type="simple" xlink:href="http://jama.ama-assn.org/cgi/content/abstract/285/10/1299?ijkey=26825a5fbea146e584cd6459ea113828f4f202fa&amp;keytype2=tf_ipsecsha">
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.</weblink> JAMA. 2001 Mar 14;285(10):1299-307.</entry>
<entry id="55">
<weblink xlink:type="simple" xlink:href="http://nccam.nih.gov/health/stjohnswort/sjwataglance.htm">
St. John's Wort and Depression</weblink> <link xlink:type="simple" xlink:href="../043/391043.xml">
NCCAM</link> on St John's wort and depression]</entry>
<entry id="54">
 <cite style="font-style:normal">Linde K, Mulrow CD, Berner M, Egger M&#32;(2005).&#32;"St John's wort for depression". <it>Cochrane Database Syst Rev</it>&#32;(2): CD000448. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD000448.pub2">
10.1002/14651858.CD000448.pub2</weblink>. PMID 15846605.</cite>&nbsp;</entry>
<entry id="53">
 <cite style="font-style:normal" class="book"><link xlink:type="simple" xlink:href="../680/429680.xml">
National Institute for Clinical Excellence</link>&#32;(2003). <weblink xlink:type="simple" xlink:href="http://www.nice.org.uk/nicemedia/pdf/59ectfullguidance.pdf">
Guidance on the use of electroconvulsive therapy</weblink>&#32;(PDF),&#32;London:&#32;National Institute for Health and Clinical Excellence. ISBN 1-84257-282-2.</cite>&nbsp;</entry>
<entry id="52">
American Psychiatric Association.&#32;"<weblink xlink:type="simple" xlink:href="http://www.psych.org/research/apire/training_fund/clin_res/index.cfm">
Electroconvulsive Therapy (ECT)</weblink>".&#32;Retrieved on <link>
2007-12-29</link>.</entry>
<entry id="59">
"<weblink xlink:type="simple" xlink:href="http://www.geriatrictimes.com/g010923.html">
Investigating SAM-e</weblink>".&#32;  Geriatric Times&#32;(2001).&#32;Retrieved on <link>
2006-12-08</link>.
</entry>
<entry id="58">
 <cite style="font-style:normal">Bressa GM&#32;(1994).&#32;"S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies". <it>Acta Neurol. Scand., Suppl.</it>&#32;<b>154</b>: 7–14. PMID 7941964.</cite>&nbsp;</entry>
<entry id="57">
 <cite style="font-style:normal">Mischoulon D, Fava M&#32;(November 2002).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/pmidlookup?view=long&amp;pmid=12420702">
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence</weblink>". <it>Am. J. Clin. Nutr.</it>&#32;<b>76</b>&#32;(5): 1158S–61S. PMID 12420702.</cite>&nbsp;</entry>
<entry id="56">
<weblink xlink:type="simple" xlink:href="http://www.nimh.nih.gov/health/publications/depression/treatment.shtml">
How is depression detected and treated?</weblink> <agency wordnetid="108337324" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../909/455909.xml">
NIMH</link></agency>
 on depression, including a section on St John's wort</entry>
<entry id="63">
 <cite style="font-style:normal">Golden RN, Gaynes BN, Ekstrom RD, et al&#32;(April 2005).&#32;"The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence". <it>American Journal of Psychiatry</it>&#32;<b>162</b>&#32;(4): 656–62. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.162.4.656">
10.1176/appi.ajp.162.4.656</weblink>. PMID 15800134.</cite>&nbsp;</entry>
<entry id="62">
 <cite style="font-style:normal">Rush AJ, Marangell LB, Sackeim HA, et al.&#32;(September 2005).&#32;"Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial". <it>Biological Psychiatry</it>&#32;<b>58</b>&#32;(5): 347–54. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2005.05.025">
10.1016/j.biopsych.2005.05.025</weblink>. PMID 16139580.</cite>&nbsp;</entry>
<entry id="61">
 <cite style="font-style:normal">Eranti S, Mogg A, Pluck G, et al&#32;(January 2007).&#32;"A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression". <it>Am J Psychiatry</it>&#32;<b>164</b>&#32;(1): 73–81. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.164.1.73">
10.1176/appi.ajp.164.1.73</weblink>. PMID 17202547.</cite>&nbsp;</entry>
<entry id="60">
 <cite style="font-style:normal">Schutter DJ&#32;(April 2008).&#32;"Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis". <it>Psychol Med</it>: 1–11. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1017%2FS0033291708003462">
10.1017/S0033291708003462</weblink>. PMID 18447962.</cite>&nbsp;</entry>
<entry id="68">
 <cite id="CITEREFNick_Higham2008" style="font-style:normal">Nick Higham&#32;(23 May 2008),&#32;<it><weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/1/hi/sci/tech/7417516.stm">
Putting a spring in your step</weblink></it>, BBC, </cite>&nbsp;</entry>
<entry id="69">
 <cite id="CITEREF1999" style="font-style:normal"><it><weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/1/hi/health/332459.stm">
Gardening aids mentally ill</weblink></it>, BBC, 1 May, 1999, </cite>&nbsp;</entry>
<entry id="70">
 <cite style="font-style:normal">Marangell LB, Martinez M, Jurdi RA, Zboyan H&#32;(September 2007).&#32;"Neurostimulation therapies in depression: a review of new modalities". <it>Acta Psychiatr Scand</it>&#32;<b>116</b>&#32;(3): 174–81. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1111%2Fj.1600-0447.2007.01033.x">
10.1111/j.1600-0447.2007.01033.x</weblink>. PMID 17655558.</cite>&nbsp;</entry>
<entry id="71">
 <cite style="font-style:normal">Shaw K, Turner J, Del Mar C&#32;(2002).&#32;"Tryptophan and 5-hydroxytryptophan for depression". <it>Cochrane Database Syst Rev</it>&#32;(1): CD003198. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD003198">
10.1002/14651858.CD003198</weblink>. PMID 11869656.</cite>&nbsp;</entry>
<entry id="64">
 <cite style="font-style:normal">Tuunainen A, Kripke DF, Endo T&#32;(2004).&#32;"Light therapy for non-seasonal depression". <it>Cochrane Database Syst Rev</it>&#32;(2): CD004050. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD004050.pub2">
10.1002/14651858.CD004050.pub2</weblink>. PMID 15106233.</cite>&nbsp;</entry>
<entry id="65">
  <cite style="font-style:normal">Smith, CA; PPJ Hay&#32;(2004-03-17).&#32;"<weblink xlink:type="simple" xlink:href="http://www.cochrane.org/reviews/en/ab004046.html">
Acupuncture for depression</weblink>". <it>Cochrane Database of Systematic Reviews</it>&#32;<b>2005</b>&#32;(2): CD004046. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD004046.pub2">
10.1002/14651858.CD004046.pub2</weblink>. Retrieved on <link>
2008-05-02</link>.</cite>&nbsp;</entry>
<entry id="66">
Merritt, Richard&#32;(2000-09-22).&#32;"<weblink xlink:type="simple" xlink:href="http://dukenews.duke.edu/2000/09/exercise922.html">
Study: Exercise Has Long-Lasting Effect on Depression</weblink>".&#32;  Duke University News.&#32;Retrieved on <link>
2007-10-20</link>.</entry>
<entry id="67">
 <cite id="CITEREFKeith_W._Johnsgard2004" style="font-style:normal">Keith W. Johnsgard&#32;(2004),&#32;<it><weblink xlink:type="simple" xlink:href="http://books.google.co.uk/books?id=A6oIAAAACAAJ">
Conquering Depression and Anxiety Through Exercise</weblink></it>, ISBN 9781591021926, </cite>&nbsp;</entry>
<entry id="76">
 <cite style="font-style:normal">Wolkowitz OM, Reus VI, Keebler A, et al.&#32;(April 1999).&#32;"<weblink xlink:type="simple" xlink:href="http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&amp;pmid=10200751">
Double-blind treatment of major depression with dehydroepiandrosterone</weblink>". <it>American Journal of Psychiatry</it>&#32;<b>156</b>&#32;(4): 646–49. PMID 10200751.</cite>&nbsp;</entry>
<entry id="77">
 <cite style="font-style:normal">Schmidt PJ, Daly RC, Bloch M, et al.&#32;(February 2005).&#32;"Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression". <it>Archives of General Psychiatry</it>&#32;<b>62</b>&#32;(2): 154–62. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Farchpsyc.62.2.154">
10.1001/archpsyc.62.2.154</weblink>. PMID 15699292.</cite>&nbsp;</entry>
<entry id="78">
 <cite style="font-style:normal">Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR&#32;(September 2005).&#32;"<weblink xlink:type="simple" xlink:href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1527-4160&amp;volume=11&amp;issue=5&amp;spage=302">
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving</weblink>". <it>J Psychiatr Pract</it>&#32;<b>11</b>&#32;(5): 302–14. PMID 16184071.</cite>&nbsp;</entry>
<entry id="79">
 <cite style="font-style:normal">Nowak G, Siwek M, Dudek D, Zieba A, Pilc A&#32;(2003).&#32;"<weblink xlink:type="simple" xlink:href="http://www.if-pan.krakow.pl/pjp/pdf/2003/6_1143.pdf">
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study</weblink>". <it>Pol J Pharmacol</it>&#32;<b>55</b>&#32;(6): 1143–7. PMID 14730113.</cite>&nbsp;</entry>
<entry id="72">
 <cite style="font-style:normal">Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW&#32;(1982).&#32;"The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo". <it>Psychological medicine</it>&#32;<b>12</b>&#32;(4): 741–51. PMID 7156248.</cite>&nbsp;</entry>
<entry id="73">
 <cite style="font-style:normal">Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM&#32;(2000).&#32;"<weblink xlink:type="simple" xlink:href="http://www.cma.ca/index.cfm/ci_id/12652/la_id/1.htm">
Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects</weblink>". <it>Journal of psychiatry &amp; neuroscience : JPN</it>&#32;<b>25</b>&#32;(4): 337–46. PMID 11022398.</cite>&nbsp;</entry>
<entry id="74">
 <cite style="font-style:normal">Appleton KM, Hayward RC, Gunnell D, et al&#32;(December 2006).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/pmidlookup?view=long&amp;pmid=17158410">
Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials</weblink>". <it>Am. J. Clin. Nutr.</it>&#32;<b>84</b>&#32;(6): 1308–16. PMID 17158410.</cite>&nbsp;</entry>
<entry id="75">
http://ajp.psychiatryonline.org/cgi/content/abstract/163/6/969  Am J Psychiatry 163:969-978, June 2006
doi: 10.1176/appi.ajp.163.6.969]</entry>
<entry id="85">
 <cite style="font-style:normal">Philip P, Demotes-Mainard J, Bourgeois M, Vincent JD&#32;(March 1991).&#32;"Efficiency of transcranial electrostimulation on anxiety and insomnia symptoms during a washout period in depressed patients. A double-blind study". <it>Biol. Psychiatry</it>&#32;<b>29</b>&#32;(5): 451–6. PMID 2018818.</cite>&nbsp;</entry>
<entry id="84">
 <cite style="font-style:normal">Passini FG, Watson CG, Herder J&#32;(1976).&#32;"The effects of cerebral electric therapy (electrosleep) on anxiety, depression, and hostility in psychiatric patients". <it>J. Nerv. Ment. Dis.</it>&#32;<b>163</b>&#32;(4): 263–6. PMID 972328.</cite>&nbsp;</entry>
<entry id="87">
 <cite style="font-style:normal">Feighner JP, Brown SL, Olivier JE&#32;(1973).&#32;"Electrosleep therapy. A controlled double blind study". <it>J. Nerv. Ment. Dis.</it>&#32;<b>157</b>&#32;(2): 121–8. PMID 4724809.</cite>&nbsp;</entry>
<entry id="86">
 <cite style="font-style:normal">Moore JA, Mellor CS, Standage KF, Strong H&#32;(1975).&#32;"A double-blind study of electrosleep for anxiety and insomnia". <it>Biol. Psychiatry</it>&#32;<b>10</b>&#32;(1): 59–63. PMID 1091305.</cite>&nbsp;</entry>
<entry id="81">
<weblink xlink:type="simple" xlink:href="http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?FR=882.5800">
FDA &amp;gt; CDRH &amp;gt; CFR Title 21 Database Search</weblink></entry>
<entry id="80">
 <cite id="CITEREFGabriel_Nowak.2C_Bernadeta_Szewczyk.2C_Andrzej_Pilc2005" style="font-style:normal">Gabriel Nowak, Bernadeta Szewczyk, Andrzej Pilc&#32;(2005),&#32;"<weblink xlink:type="simple" xlink:href="http://www.if-pan.krakow.pl/pjp/pdf/2005/6_713.pdf">
Zinc and depression.</weblink>",&#32;<it>Pharmacological Reports</it>, </cite>&nbsp;</entry>
<entry id="83">
 <cite style="font-style:normal">Levitt EA, James NM, Flavell P&#32;(December 1975).&#32;"A clinical trial of electrosleep therapy with a psychiatric inpatient sample". <it>Aust N Z J Psychiatry</it>&#32;<b>9</b>&#32;(4): 287–90. PMID 769773.</cite>&nbsp;</entry>
<entry id="82">
<weblink xlink:type="simple" xlink:href="http://www.fda.gov/cdrh/ode/515iltr.html">
FDA 515(i) Reclassification Letter to Manufacturers</weblink></entry>
<entry id="93">
 <cite style="font-style:normal">Palatnik A, Frolov K, Fux M, Benjamin J&#32;(2001).&#32;"Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder". <it>Journal of Clinical Psychopharmacology</it>&#32;<b>21</b>&#32;(3): 335&ndash;339. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1097%2F00004714-200106000-00014">
10.1097/00004714-200106000-00014</weblink>. PMID 11386498.</cite>&nbsp;</entry>
<entry id="92">
 <cite style="font-style:normal">Deyama T, Nishibe S, Nakazawa Y&#32;(Dec 2001).&#32;"Constituents and pharmacological effects of Eucommia and Siberian ginseng". <it>Acta Pharmacol. Sin.</it>&#32;<b>22</b>&#32;(12): 1057–70. PMID 11749801.</cite>&nbsp;</entry>
<entry id="95">
 <cite style="font-style:normal">Di Paolo G, De Camilli P&#32;(2006).&#32;"Phosphoinositides in cell regulation and membrane dynamics". <it>Nature</it>&#32;<b>443</b>&#32;(7112): 651–7. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fnature05185">
10.1038/nature05185</weblink>. PMID 17035995.</cite>&nbsp;</entry>
<entry id="94">
 <cite style="font-style:normal">Fux M, Levine J, Aviv A, Belmaker RH&#32;(1996).&#32;"Inositol treatment of obsessive-compulsive disorder". <it>American Journal of Psychiatry</it>&#32;<b>153</b>&#32;(9): 1219&ndash;21. PMID 8780431.</cite>&nbsp;</entry>
<entry id="89">
 <cite style="font-style:normal">Shealy CN&#32;(October 2003).&#32;"Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression". <it>J Altern Complement Med</it>&#32;<b>9</b>&#32;(5): 619–23. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1089%2F107555303322524463">
10.1089/107555303322524463</weblink>. PMID 14629839.</cite>&nbsp;</entry>
<entry id="88">
 <cite style="font-style:normal">Feighner JP&#32;(1971).&#32;"<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1518073">
Electrosleep Therapy: Current Usage in Psychiatry</weblink>". <it>Calif. Med.</it>&#32;<b>115</b>&#32;(3): 44. PMID 18730592. Retrieved on <link>
2007-12-02</link>.</cite>&nbsp;</entry>
<entry id="91">
 <cite id="CITEREFV._A._Kurkin1.2C_A._V._Dubishchev1.2C_V._N._Ezhkov1.2C_I._N._Titova1_and_E._V._Avdeeva12009" style="font-style:normal">V. A. Kurkin1, A. V. Dubishchev1, V. N. Ezhkov1, I. N. Titova1 and E. V. Avdeeva1&#32;(November, 2006),&#32;"<weblink xlink:type="simple" xlink:href="http://www.springerlink.com/content/t6512435001n1418/">
Antidepressant activity of some phytopharmaceuticals and phenylpropanoids</weblink>",&#32;<it>Pharmaceutical Chemistry Journal</it>&#32;<b>40</b>:  614-619, <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs11094-006-0205-5">
10.1007/s11094-006-0205-5</weblink>, </cite>&nbsp;</entry>
<entry id="90">
 <cite style="font-style:normal">Shealy CN, Thomlinson P&#32;(2008).&#32;"<weblink xlink:type="simple" xlink:href="http://chp.sagepub.com/cgi/content/abstract/13/2/92">
Safe Effective Nondrug Treatment of Chronic Depression: A Review of Research on Low-Voltage Cranial Electrical Stimulation and Other Adjunctive Therapies</weblink>". <it>Complementary Health Practice Review</it>&#32;<b>13</b>&#32;(2): 92–99. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1177%2F1533210108317232">
10.1177/1533210108317232</weblink>.</cite>&nbsp;</entry>
<entry id="102">
<weblink xlink:type="simple" xlink:href="http://discovermagazine.com/2005/may/vitamin-cure/?page=1">
discovermagazine.com (May 2005)</weblink></entry>
<entry id="103">
<weblink xlink:type="simple" xlink:href="http://erowid.org/plants/kanna/kanna_journal1.shtml">
Psychoactive constituents of the genus Sceletium N.E.Br. and other Mesembryanthemaceae: a review.</weblink></entry>
<entry id="100">
 <cite style="font-style:normal">Fux M, Levine J, Aviv A, Belmaker RH&#32;(1996).&#32;"Inositol treatment of obsessive-compulsive disorder". <it>American Journal of Psychiatry</it>&#32;<b>153</b>&#32;(9): 1219&ndash;21. PMID 8780431.</cite>&nbsp;</entry>
<entry id="101">
 <cite style="font-style:normal">Di Paolo G, De Camilli P&#32;(2006).&#32;"Phosphoinositides in cell regulation and membrane dynamics". <it>Nature</it>&#32;<b>443</b>&#32;(7112): 651–7. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fnature05185">
10.1038/nature05185</weblink>. PMID 17035995.</cite>&nbsp;</entry>
<entry id="98">
 <cite id="CITEREFG._Eby.2C_K._Eby" style="font-style:normal">G. Eby, K. Eby,&#32;"<weblink xlink:type="simple" xlink:href="http://linkinghub.elsevier.com/retrieve/pii/S0306987706001034">
Rapid recovery from major depression using magnesium treatment.</weblink>",&#32;<it>Medical Hypotheses</it>, </cite>&nbsp;</entry>
<entry id="99">
 <cite style="font-style:normal">Palatnik A, Frolov K, Fux M, Benjamin J&#32;(2001).&#32;"Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder". <it>Journal of Clinical Psychopharmacology</it>&#32;<b>21</b>&#32;(3): 335&ndash;339. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1097%2F00004714-200106000-00014">
10.1097/00004714-200106000-00014</weblink>. PMID 11386498.</cite>&nbsp;</entry>
<entry id="96">
"<weblink xlink:type="simple" xlink:href="http://www.actahort.org/books/650/650_54.htm">
Antidepressant effect of Crocus sativus L. stigma extracts and their constituents, crocin and safranal, in mice.</weblink>".&#32;Retrieved on <link>
2008-08-17</link>.
</entry>
<entry id="97">
 <cite id="CITEREFBryan_L._Court.2C_Court.2C_Gerald_E._Nelson.2C_L._Court_Bryan1996" style="font-style:normal">Bryan L. Court, Court, Gerald E. Nelson, L. Court Bryan&#32;(1996),&#32;<it><weblink xlink:type="simple" xlink:href="http://books.google.co.uk/books?id=qq1DZjH0K6cC">
Bipolar Puzzle Solution</weblink></it>, Taylor &amp; Francis, pp. 57, ISBN 9781560324935, </cite>&nbsp;</entry>
<entry id="110">
 <cite id="Reference-White-1991" style="font-style:normal" class="book">White, Ian&#32;(1991). Australian Bush Flower Essences.</cite>&nbsp;</entry>
<entry id="111">
The Homeopathy Bible, Ambika Wauters (Godsfield Publications) 2007 ISBN 184181 306 0</entry>
<entry id="108">
 <cite id="Reference-Gurudas-1983" style="font-style:normal" class="book">Gurudas&#32;(1983). Flower Essences and Vibrational Healing.</cite>&nbsp;</entry>
<entry id="109">
 <cite id="Reference-Ball-1998" style="font-style:normal" class="book">Ball, Stefan&#32;(1998). The Bach Remedies Workbook.</cite>&nbsp;</entry>
<entry id="106">
 <cite style="font-style:normal">E. Ernst&#32;(December 30 2002).&#32;""Flower remedies": a systematic review of the clinical evidence". <it>Wiener Klinische Wochenschrift</it>&#32;<b>114</b>&#32;(23-24): 963–966. PMID 12635462.</cite>&nbsp;</entry>
<entry id="107">
 <cite id="Reference-Bach-1931" style="font-style:normal" class="book">Bach, Dr Edward&#32;(1931). Heal Thyself.</cite>&nbsp;</entry>
<entry id="104">
<weblink xlink:type="simple" xlink:href="http://www.plantzafrica.com/medmonographs/scelettort.pdf">
www.plantzafrica.com</weblink></entry>
<entry id="105">
Pharmaceutical compositions containing mesembrine and related compounds. <weblink xlink:type="simple" xlink:href="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6,288,104">
U.S. Patent 6,288,104</weblink> 
<weblink xlink:type="simple" xlink:href="http://www.pat2pdf.org/pat2pdf/foo.pl?number=6,288,104">
(PDF)</weblink></entry>
<entry id="118">
 <cite id="CITEREF2008" style="font-style:normal">"<weblink xlink:type="simple" xlink:href="http://www.ingentaconnect.com/content/bpsoc/bjcp/2008/00000047/00000003/art00005">
Effects of mindful and non-mindful exercises on people with depression: A systematic review</weblink>",&#32;<it>British Journal of Clinical Psychology</it>:  303-322, September 2008, </cite>&nbsp;</entry>
<entry id="117">
 <cite id="CITEREF2004" style="font-style:normal"><it><weblink xlink:type="simple" xlink:href="http://www.nice.org.uk/nicemedia/pdf/CG023NICEguideline.pdf">
Depression</weblink></it>, NICE, December 2004, </cite>&nbsp;</entry>
<entry id="116">
 <cite id="CITEREFHarold_George_Koenig2005" style="font-style:normal">Harold George Koenig&#32;(2005),&#32;<it><weblink xlink:type="simple" xlink:href="http://books.google.co.uk/books?id=B9bSdb7bLckC">
Faith And Mental Health</weblink></it>, ISBN 9781932031911, </cite>&nbsp;</entry>
<entry id="115">
 <cite id="CITEREFPaul_G._Swingle2008" style="font-style:normal">Paul G. Swingle&#32;(2008),&#32;<it><weblink xlink:type="simple" xlink:href="http://books.google.co.uk/books?id=uqPqRIb9wCAC">
Biofeedback for the Brain</weblink></it>, ISBN 9780813542874, </cite>&nbsp;</entry>
<entry id="114">
 <cite id="CITEREFJames_Strohecker.2C_Nancy_Shaw_Strohecker.2C_David_E._Bresler1999" style="font-style:normal">James Strohecker, Nancy Shaw Strohecker, David E. Bresler&#32;(1999),&#32;<weblink xlink:type="simple" xlink:href="http://books.google.co.uk/books?id=R60NAAAACAAJ">
"2,4,10"</weblink>,&#32;<it>Natural Healing for Depression</it>, ISBN 9780399525377, </cite>&nbsp;</entry>
<entry id="113">
 <cite id="Reference-Bricklin-1983" style="font-style:normal" class="book">Bricklin, Mark&#32;(1983). Natural Healing.</cite>&nbsp;</entry>
<entry id="112">
 <cite id="Reference-Benson-1996" style="font-style:normal" class="book">Benson, Dr Herbert&#32;(1996). Timeless Healing.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
</bdy>
</treatment>
</article>
